USP's Finalized Model For Medicare Rx Formularies Retains 146 Drug Groups
This article was originally published in The Pink Sheet Daily
Executive Summary
Overall, the model guidelines resemble the version proposed by USP in August but include revisions to specific therapeutic categories and pharmacologic classes. Proton pump inhibitors are placed in a separate drug class; SSRIs/SNRIs remain off the formal chart.